The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study

The potential impact of diagnostic delays on patients’ outcomes is a debated issue in pediatric oncology and discordant results have been published so far. We attempted to tackle this issue by analyzing a prospective series of 351 consecutive children and adolescents with solid malignancies using innovative statistical tools.

[1]  A. Ferrari,et al.  Clouds of oxygen: adolescents with cancer tell their story in music. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Ferrari SIAMO: Italian Pediatric Oncologists and Adult Medical Oncologists Join Forces for Adolescents with Cancer , 2014, Pediatric hematology and oncology.

[3]  O. Oberlin,et al.  Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Barr “Delays” in Diagnosis: A Misleading Concept, Yet Providing Opportunities for Advancing Clinical Care , 2014, Journal of pediatric hematology/oncology.

[5]  P. Ravaud,et al.  Quality of reporting of studies evaluating time to diagnosis: a systematic review in paediatrics , 2013, Archives of Disease in Childhood.

[6]  A. Ferrari The Challenge of Access to Care for Adolescents with Cancer in Italy: National and Local Pediatric Oncology Programs. International Perspectives on AYAO, Part 2. , 2013, Journal of adolescent and young adult oncology.

[7]  L. Mariani,et al.  Symptom interval in pediatric patients with solid tumors: Adolescents are at greater risk of late diagnosis , 2013, Pediatric blood & cancer.

[8]  R. Feltbower,et al.  A systematic review of time to diagnosis in children and young adults with cancer , 2013, Archives of Disease in Childhood.

[9]  P. Vedsted,et al.  Childhood cancer and factors related to prolonged diagnostic intervals: a Danish population-based study , 2013, British Journal of Cancer.

[10]  J. Grill,et al.  Delays in diagnosis of paediatric cancers: a systematic review and comparison with expert testimony in lawsuits. , 2012, The Lancet. Oncology.

[11]  A. Ferrari,et al.  The Youth Project at the Istituto Nazionale Tumori in Milan , 2012, Tumori.

[12]  A. Loh,et al.  Diagnostic delay in pediatric solid tumors: A population based study on determinants and impact on outcomes , 2012, Pediatric blood & cancer.

[13]  N. Olgun,et al.  The time to diagnosis in childhood lymphomas and other solid tumors , 2011, Pediatric blood & cancer.

[14]  N. Carlsen,et al.  Symptoms and time to diagnosis in children with brain tumours. , 2011, Danish medical bulletin.

[15]  M. Ewertz,et al.  Utility of 18FDG-PET/CT in breast cancer diagnostics--a systematic review. , 2011, Danish medical bulletin.

[16]  M. Ben Arush,et al.  The role of the doctor and the medical system in the diagnostic delay in pediatric malignancies. , 2011, Cancer epidemiology.

[17]  Mark L. Greenberg,et al.  Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada , 2010, International journal of cancer.

[18]  L. Mariani,et al.  The symptom interval in children and adolescents with soft tissue sarcomas , 2009, Cancer.

[19]  A. Loh,et al.  Delays in Diagnosis of Pediatric Solid Tumors in Singapore , 2009, Journal of pediatric hematology/oncology.

[20]  J. Coebergh,et al.  Survival of European children and young adults with cancer diagnosed 1995-2002. , 2009, European journal of cancer.

[21]  E. Boltshauser,et al.  Does diagnostic delay result in decreased survival in paediatric brain tumours? , 2009, European Journal of Pediatrics.

[22]  A. Ferrari,et al.  Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. , 2009, European journal of cancer.

[23]  Mark L. Greenberg,et al.  Delays in diagnosis and treatment among children and adolescents with cancer in Canada , 2008, Pediatric blood & cancer.

[24]  Gerhard Kurlemann,et al.  Brain Tumors in Children: Initial Symptoms and Their Influence on the Time Span Between Symptom Onset and Diagnosis , 2008, Journal of child neurology.

[25]  A. Bleyer,et al.  Participation of adolescents with cancer in clinical trials. , 2007, Cancer treatment reviews.

[26]  M. Santi,et al.  CNS germ cell tumor (CNSGCT) of childhood , 2007, Neurology.

[27]  H. Gattamaneni,et al.  Symptom interval in young people with bone cancer. , 2004, European journal of cancer.

[28]  M. Haimi,et al.  DELAY IN DIAGNOSIS OF CHILDREN WITH CANCER: A Retrospective Study of 315 Children , 2003, Pediatric hematology and oncology.

[29]  Leslie Bernstein,et al.  Childhood cancer patients' access to cooperative group cancer programs , 2003, Cancer.

[30]  V. Mehta,et al.  Latency between Symptom Onset and Diagnosis of Pediatric Brain Tumors: An Eastern Canadian Geographic Study , 2002, Neurosurgery.

[31]  J. Mejía-Aranguré,et al.  Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. , 2002, Medical and pediatric oncology.

[32]  S. George,et al.  Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma , 2001, Cancer.

[33]  A. Håkansson,et al.  Diagnostic Delay in Pediatric Malignancies - A Population-based Study , 2000, Acta oncologica.

[34]  A. Bleyer,et al.  National cancer clinical trials: children have equal access; adolescents do not. , 1997, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[35]  S. Love,et al.  Determinants of symptom interval in childhood cancer. , 1993, Archives of disease in childhood.

[36]  J. Krischer,et al.  Interval between symptom onset and diagnosis of pediatric solid tumors. , 1991, The Journal of pediatrics.

[37]  D. Williams,et al.  Delay in the diagnosis of pediatric brain tumors. , 1986, American journal of diseases of children.

[38]  C. Pratt,et al.  Factors leading to delay in the diagnosis and affecting survival of children with head and neck rhabdomyosarcoma. , 1978, Pediatrics.

[39]  A. Fattal-Valevski,et al.  Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis , 2011, Child's Nervous System.

[40]  S. Puget,et al.  Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study , 2011, European Journal of Pediatrics.

[41]  W. Loh,et al.  REGRESSION TREES WITH UNBIASED VARIABLE SELECTION AND INTERACTION DETECTION , 2002 .

[42]  S. Morgan,et al.  The adolescent with cancer--at the edge of no-man's land. , 2001, The Lancet. Oncology.